Halia Presents Ofirnoflast Phase 2 Data in Lower-Risk MDS at EHA
12 May 2026 //
PR NEWSWIRE
Halia Therapeutics Reports Ofirnoflast Success In Lower-Risk MDS
08 Dec 2025 //
PR NEWSWIRE
Halia Therapeutics Unveils Novel NEK7 Inhibitor Data At ASH 2025
10 Nov 2025 //
PR NEWSWIRE
Ofirnoflast Gets Orphan Drug Tag for Myelodysplastic Syndromes
23 Oct 2025 //
PR NEWSWIRE

Market Place
Sourcing Support